AdaptHealth Corp. (AHCO) — Financial statements
Income statement, balance sheet, and cash flow for AdaptHealth Corp. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,245↓0.5% | 3,261↑1.9% | 3,200↑7.7% | 2,971↑21.0% | 2,455 | |
| Cost of Revenue | 2,676↑3.7% | 2,580↑2.4% | 2,518↓1.4% | 2,553↑27.1% | 2,009 | |
| Gross Profit | 569↓16.5% | 681↓0.1% | 682↑63.3% | 417↓6.3% | 446 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 382↑6.4% | 359↑89.0% | 190↑17.2% | 162↓3.2% | 168 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 382↑6.4% | 359↑89.0% | 190↑17.2% | 162↓3.2% | 168 | |
| Other Expenses | 0.00↓100.0% | 58↓94.7% | 1,090↑1579.9% | 65↑23.6% | 53 | |
| Operating Expenses | 382↓8.4% | 417↓67.4% | 1,280↑463.9% | 227↑3.2% | 220 | |
| Total Costs & Expenses | 3,059↑2.0% | 2,997↓21.1% | 3,799↑36.6% | 2,780↑24.7% | 2,229 | |
| Operating Results | ||||||
| Operating Income | 186↓29.4% | 264↑144.1% | -598↓414.3% | 190↓15.6% | 226 | |
| Depreciation & Amortization | 413↑13.1% | 365↓13.1% | 421↓0.7% | 423↑64.1% | 258 | |
| EBITDA | 504↓19.8% | 628↑467.1% | -171↓127.1% | 631↑15.9% | 544 | |
| EBIT | 91↓65.5% | 263↑144.4% | -592↓385.4% | 207↓27.6% | 286 | |
| Interest & Other Income | ||||||
| Net Interest Income | -106↑16.5% | -127↑2.8% | -130↓19.1% | -109↓14.9% | -95 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 106↓16.5% | 127↓2.8% | 130↑19.1% | 109↑14.9% | 95 | |
| Non-Operating Income | 96↑9054.7% | 1↑115.6% | -7↑60.3% | -17↑72.1% | -61 | |
| Other Income / Expenses | -201↓57.7% | -128↓1.9% | -125↓35.5% | -93↓167.0% | -35 | |
| Income Before Tax | -15↓111.1% | 136↑118.8% | -724↓839.3% | 98↓48.7% | 191 | |
| Income Tax Expense | 51↑23.4% | 41↑184.2% | -49↓297.8% | 25↓24.5% | 33 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -66↓169.7% | 95↑114.0% | -675↓1022.7% | 73↓53.8% | 158 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -71↓178.3% | 90↑113.3% | -679↓1079.4% | 69↓55.6% | 156 | |
| Bottom-Line Net Income | -71↓185.6% | 83↑111.6% | -713↓1224.3% | 63↓28.4% | 89 | |
| EPS (Basic) | -0.52↓183.9% | 0.62↑111.7% | -5.32↓1123.1% | 0.52↓53.6% | 1.12 | |
| EPS (Diluted) | -0.52↓185.2% | 0.61↑111.5% | -5.31↓1162.0% | 0.50↓25.4% | 0.67 | |
| Weighted Average Shares | 135↑1.0% | 134↓0.3% | 134↓0.0% | 134↑6.2% | 126 | |
| Weighted Average Diluted Shares | 135↓0.3% | 136↑0.8% | 134↓3.3% | 139↑4.5% | 133 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.